BioTrove said this week that Charles River Laboratories has purchased an OpenArray system for use in detecting rodent-specific pathogens.
Charles River had previously purchased an OpenArray SNP Genotyping system for genetic quality control processes. The firm is designing pathogen panels using OpenArray plates, which can contain between 16 and 3,072 assays and can be loaded with up to 144 samples.
“Our new OpenArray system will now enable us to screen samples with custom-designed pathogen panels that utilize our pre-existing fluorogenic PCR technology,” said Kenneth Henderson, director of molecular diagnostics and R&D for Charles River, in a statement.
The firm believes its fluorogenic PCR technology is more specific and sensitive than conventional gel-based PCR.